14C by KULKARNI'S method (7) . Specific activity of tritiated 7-dehydrocholesterol was 2,800dpm/pmole and that of the 14C labeled one was 800dpm/pmole . Vita min D3-1, 2-3H (540mCi/mmole) was purchased from New England Nuclear Co ., U. S. A. Radioactive material was purified before the experiment by thin layer chromatography using silica gel G in vitamin D3-3H and silica gel-silver nitrate (5% silver nitrate to silica gel) in labeled 7-dehydrocholesterol with benzene acetone (9:1) as a developing solvent (8) .
RESULTS

Interaction of 7-dehydrocholesterol or vitamin D3 with sterol cagier protein in rat liver
The binding of 7-dehydrocholesterol or vitamin D3 with SCP was studied in various sterol concentrations. Results were analyzed according to the SCATCHARD method (9) .
The Scatchard plot of binding data follows the equation below. The figures were extrapolated graphically from intercept of ordinate (nk) and abscissa (n) of Scatchard plot in Fig. 1. 2. Analysis and characterization of the sterol-sterol carrier protein complex SCP showed a distinct difference in binding with 7-dehydrocholesterol and vitamin D3. Therefore, the partially purified SCP was further fractionated on a Sephadex G-100 column and the binding of each fractionated SCP with 7-dehy drocholesterol and vitamin D3 was investigated. Figure 2 shows the gel filtration pattern of partially purified liver SCP on Sephadex G-100 column. The large molecular weight protein emerging at void volume of the column (peak I protein) and two other small molecular weight protein peaks (peaks IT and III protein according to the elution orders) were isolated. In order to find out which protein peak has binding activity for 7-dehydro cholesterol-14C or vitamin D3-3H, the partially purified SCP was incubated with either 7-dehydrocholesterol-14C (9.1 nmoles, 7,450 dpm) or vitamin D3-3H (18.1 nmoles, 28,400 dpm) prior to gel filtration. After the incubation, the mixture was applied on a Sephadex G-100 column. The elution profiles are shown in Figs. 3-A and 4-A. The radioactivity of 7-dehydrocholesterol-14C and vitamin D3-3H was eluted at void volume in association with peak I protein. No radioactivity was associated with peaks II or III protein.
We examined the binding capacity of peaks I, II and III protein with 7 -dehydrocholesterol-14C or vitamin D3-3H, respectively. Each protein peak was pooled after gel filtration of partially purified SCP on Sephadex G-100 column. Fraction number 13-15 was used for peak I protein, fraction 22-24 for peak II protein and fraction 31-33 for peak III protein, respectively (Fig. 3 ). An aliquot of each peak protein was incubated with radioactive sterols and then applied on a Sephadex G-100 column. Binding activity of peaks I, II and III protein with 7-dehydrocholesterol-14C is shown in Fig. 3 -B, -C and -D. Although original peak III protein contained no protein eluting at void volume before the incubation with 7-dehydrocholesterol-14C, a new protein peak appeared at void volume as sociated with the radioactivity after incubation. No radioactivity was detected Fig. 3 . Fig. 4 . in the peak III region (Fig. 3-D) . The new protein peak aggregated during the sterol protein complex formation. The appearance of new protein peak as sociated with radioactivity at void volume implicates evidence of the capacity to bind sterol. Peak I protein could bind more 7-dehydrocholesterol ( Fig. 3-B) , however, peak II protein could not bind 7-dehydrocholesterol ( Fig. 3-C) . The evidence demonstrated that vitamin D3-3H bound to peaks II and III protein, respectively, and radioactivity was observed at void volume associated with the appearance of new protein. These new protein peaks represented vitamin D3-3H-protein complex which must be aggregated during the formation of the sterol-protein complex as well as 7-dehydrocholesterol. Peak I protein showed further binding capacity with vitamin D3 which was the same as that with 7-dehydrocholesterol (Fig. 4-B , -C and -D).
Molecular weight of peaks I, II and III protein was estimated by the calibration of Sephadex G-100 column with standard proteins. As a result, the molecular weight of peak II protein was estimated to be about 44,000, while that of peak III protein was 16,000. Peak I protein was estimated to be more than 150,000 (Fig. 5) . G-100 column was calibrated using the following standard; 2ml of the solution containing 2.0mg of blue dextran (m. w., 2,000,000), 1.0mg of crystalline bovine serum albumin (m. w., 67,000), 1.5mg of bovine pancreas chymotrypsinogen (m. w., 25,000), 1.0mg of whale sperm myoglobin (m. w.,17,800) and 0.7mg of horse cytochrome C (m. w., 12,400 
